A CD34-negative MYC-rearranged B-lymphoblastic lymphoma aberrantly expresses CD3 and CD5

Blood. 2017 Mar 9;129(10):1403. doi: 10.1182/blood-2016-10-745620.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acquired Immunodeficiency Syndrome / genetics
  • Acquired Immunodeficiency Syndrome / metabolism
  • Acquired Immunodeficiency Syndrome / pathology
  • Aged
  • Antigens, CD34*
  • CD3 Complex* / biosynthesis
  • CD3 Complex* / genetics
  • CD5 Antigens / biosynthesis
  • CD5 Antigens / genetics
  • Gene Expression Regulation, Neoplastic*
  • Gene Rearrangement*
  • HIV-1
  • Humans
  • Lymphoma, B-Cell* / genetics
  • Lymphoma, B-Cell* / metabolism
  • Lymphoma, B-Cell* / pathology
  • Male
  • Proto-Oncogene Proteins c-myc* / genetics
  • Proto-Oncogene Proteins c-myc* / metabolism

Substances

  • Antigens, CD34
  • CD3 Complex
  • CD5 Antigens
  • MYC protein, human
  • Proto-Oncogene Proteins c-myc